Key takeaways:
Wegovy (semaglutide) is a medication that can help you manage your weight, reduce the risk of a heart attack and stroke, and treat certain types of liver disease.
Wegovy can affect your bowel movements. It can cause both diarrhea and constipation. These side effects are usually mild and go away on their own.
Staying hydrated can lower the risk of dehydration from Wegovy-related diarrhea. It can also help ease Wegovy-related constipation.
Wegovy (semaglutide) is a medication that’s FDA approved for weight management and for lowering the risk of serious heart problems, like heart attacks and strokes. Injectable Wegovy is also FDA approved to treat metabolic dysfunction-associated steatohepatitis (MASH) with liver scarring.
Wegovy increases your body’s levels of glucagon-like peptide-1 (GLP-1), a hormone that affects your appetite and how quickly your stomach empties. GLP-1 also encourages your pancreas to release insulin, which helps lower blood sugar.
These changes lead to surprising side effects. Here’s how Wegovy can affect how often you go to the bathroom.
Does Wegovy cause diarrhea?
Yes, Wegovy can make you poop more often. In clinical trials for injectable Wegovy, diarrhea was the second most commonly reported side effect by adults, just after nausea. About 3 in 10 adults taking injectable Wegovy experienced diarrhea while taking the medication. Teens were slightly less likely to experience diarrhea when taking injectable Wegovy. About 2 in 10 teens experienced diarrhea, making it the third most common side effect in this group.
Diarrhea is a commonly reported side effect of the Wegovy pill too. About 3 in 10 adults taking the Wegovy pill also experienced diarrhea. So it’s likely that both forms of Wegovy cause similar rates of diarrhea.
The good news is that Wegovy-related diarrhea doesn’t seem to last very long. In studies, diarrhea lasted between 2 and 4 days.
Is it more common to experience diarrhea or constipation with Wegovy?
You might be surprised to learn that Wegovy can cause constipation in addition to diarrhea. But it’s less common to experience constipation than diarrhea while taking Wegovy.
In clinical trials, about 1 in 4 adults experienced constipation while taking injectable Wegovy, making it the fourth most commonly reported side effect. Rates were similar in adults taking Wegovy pills. Teens were less likely to experience constipation while taking injectable Wegovy. Only about 6% of teens reported constipation.
The good news is that most people in clinical trials continued taking Wegovy despite these side effects. This suggests the following:
Both Wegovy-related diarrhea and constipation are mild.
The benefits of Wegovy outweigh the discomfort of these side effects.
There’s also evidence that these side effects get better over time as your body adjusts to the medication. Diarrhea and constipation may come back if you increase your dose. But these side effects should go away as your body adjusts to the new dose.

Why does Wegovy cause bowel movement changes?
Research suggests that people develop diarrhea and constipation because of how semaglutide — the active ingredient in Wegovy — works on your gut.
How Wegovy causes diarrhea
Semaglutide changes how your body absorbs some nutrients, which can lead to diarrhea.
Semaglutide also shows down how quickly the gut moves. This normally causes constipation. But in some people, this can also trigger the stooling reflex, leading to more frequent bowel movements.
How Wegovy causes constipation
Semaglutide increases your insulin levels. This slows down your gut, which means stool sits in your colon longer. As stool sits in your colon, it becomes drier and more difficult to pass. This can lead to constipation.
Semaglutide also slows down how fast the stomach empties. This makes people feel fuller longer, so they end up eating and drinking less. If you don’t drink enough water throughout the day, you’re more likely to develop constipation. Also, since people tend to eat less while taking Wegovy, they may eat less fiber. Not getting enough fiber is a leading cause of constipation.
How can you treat digestive issues from Wegovy?
Stool changes from Wegovy usually go away on their own as your body adjusts to the medication. But there are steps you can take to ease your symptoms and make your stools more regular.
You can manage Wegovy-related diarrhea at home by:
Drinking plenty of water
Eating hydrating foods
Drinking electrolyte drinks after exercise
You can manage Wegovy-related constipation by:
Adding more fiber to your diet
Drinking plenty of water
Taking over-the-counter (OTC) constipation-relieving medications, like polyethylene glycol (MiraLAX) or docusate (Colace)
Moving more throughout the day
When should you seek medical care for stool changes from Wegovy?
Let your healthcare team know if you’re experiencing constipation or diarrhea that doesn’t get better within a few days.
Your team may want to adjust your Wegovy dose or slow down how quickly you increase your dose. They may also suggest prescription treatments that can help you manage your symptoms.
In rare cases, Wegovy-related diarrhea can lead to serious medical issues, including abnormal electrolyte levels and kidney injury. It’s rare, but Wegovy-related constipation can also be an early sign of intestinal blockage.
Contact your healthcare team right away if you have:
More than 3 episodes of diarrhea per day
Severe stomach pain
Severe stomach bloating
Inability to eat or drink due to vomiting, stomach pain, or nausea
Fever
Dark urine or less urine
Frequently asked questions
Wegovy-related diarrhea should only last a few days. Contact your healthcare team if your diarrhea lasts more than 2 days or if you have:
Bloody stools
Stomach pain
Dark urine
Trouble eating and drinking
High-fat, fried, and greasy foods can worsen Wegovy-related diarrhea. Spicy foods and alcohol can also worsen symptoms.
Wegovy has been linked to serious side effects, including:
Pancreatitis
Gallbladder problems
Stomach paralysis (gastroparesis)
Some people are at increased risk for developing thyroid cancer while taking Wegovy. You shouldn’t take Wegovy if you:
Have a personal or family history of thyroid cancer
Have multiple endocrine neoplasia type 2 (MEN2) syndrome
Are pregnant or nursing
Wegovy-related diarrhea should only last a few days. Contact your healthcare team if your diarrhea lasts more than 2 days or if you have:
Bloody stools
Stomach pain
Dark urine
Trouble eating and drinking
High-fat, fried, and greasy foods can worsen Wegovy-related diarrhea. Spicy foods and alcohol can also worsen symptoms.
Wegovy has been linked to serious side effects, including:
Pancreatitis
Gallbladder problems
Stomach paralysis (gastroparesis)
Some people are at increased risk for developing thyroid cancer while taking Wegovy. You shouldn’t take Wegovy if you:
Have a personal or family history of thyroid cancer
Have multiple endocrine neoplasia type 2 (MEN2) syndrome
Are pregnant or nursing
The bottom line
Wegovy (semaglutide) is a medication that can help with weight management and decrease the risk of a heart attack and stroke. Wegovy slows down gut movement, which can lead to diarrhea and constipation. Diarrhea and constipation are usually mild and go away as your body adjusts to the medication.
Why trust our experts?


References
Friedrichsen, M., et al. (2021). The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity. Diabetes, Obesity and Metabolism.
Jones, M., et al. (2025). GLP-1 receptor agonists in diabetes and obesity: A case report and review of bowel obstruction risks and management. Cureus.
Knop, F. K., et al. (2023). Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): A randomised, double-blind, placebo-controlled, phase 3 trial. Lancet.
National Institute of Diabetes and Digestive and Kidney Diseases. (2018). Eating, diet, & nutrition for constipation. National Institutes of Health.
Novo Nordisk. (2026). Wegovy - semaglutide tablets 25 mg and injection 2.4 mg [package insert].
Smits, M. M., et al. (2021). Safety of semaglutide. Frontiers in Endocrinology.
Wadden, T. A., et al. (2021). Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: The STEP 3 randomized clinical trial. JAMA.
Wilding, J. P. H., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. The New England Journal of Medicine.













